CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET
暂无分享,去创建一个
A. Drilon | A. Italiano | B. Geoerger | J. Grilley-Olson | D. Hong | J. Schulte | I. Øra | C. M. Tilburg | J. Chisholm | D. Ziegler | B. Ellezam | T. Laetsch | V. Boni | S. Perreault | F. Doz | M. Tahara | S. DuBois | H. Kang | K. Nysom | C. V. van Tilburg | M. Fellous | E. De La Cuesta | C. Owens | J. Reeves | H. Kang | E. D. L. Cuesta